Project of an ethical code of subjects implementing activity of creating, applying and utilizing medical products based on bioprinting technologies, interacting with patients and cell donors, turnover of donor cells, bioink and bioprint tissue (organ) constructs

Автор: Shutova A.A., Begishev I.R.

Журнал: Правопорядок: история, теория, практика @legal-order

Рубрика: Законопроекты

Статья в выпуске: 4 (39), 2023 года.

Бесплатный доступ

The draft Code of Ethics of Entities Engaged in the Creation, Use and Disposal of Medical Devices Based on bioprint technologies, interaction with patients and cell donors, turnover of donor cells, biochernils and bioprint tissue (organ) constructs (hereinafter - The Code of Ethics), is a set of general principles of professional service ethics and basic rules of official conduct, which should guide the subjects engaged in the creation, use and disposal of medical devices based on bioprint technologies, interaction with patients and cell donors, turnover of donor cells, bio-ink and bioprint tissue (organ) constructs. The presented draft Code of Ethics is aimed at strengthening the authority of medical professionals, increasing patient confidence in bioprinting technologies and preventing potential negative consequences as a result of their use. The principles reflected in the Code of Ethics serve as the basis for improving the system of legal regulation of bioprint technologies. The digital development of the healthcare system will inevitably entail a change in the regulatory regulation of bioprint technologies, therefore, the proposed draft Code of Ethics is an attempt to form ethical foundations that can be laid in the basis of the law-making process of this digital technology and its practical implementation in clinical medicine. The ethical principles in the code are divided into information blocks formed based on the stages of the implementation of bioprint technology. The draft Code of Ethics is intended for lawyers, scientists and practitioners, medical professionals, members of clinical ethics committees, medical ethics specialists, representatives of law-making bodies, government departments, the business community and public organizations, patients, as well as a wide range of readers interested in the digital transformation of the healthcare system.

Еще

3d-биопечать, 3d-биопринтер

Короткий адрес: https://sciup.org/14129145

IDR: 14129145   |   DOI: 10.47475/2311-696X-2023-39-4-239-247

Статья научная